High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors
Top Cited Papers
Open Access
- 1 March 2009
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 17 (3), 463-471
- https://doi.org/10.1038/mt.2008.269
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expressionVirology, 2008
- Treatment of Leber Congenital Amaurosis Due toRPE65Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I TrialHuman Gene Therapy, 2008
- Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kineticsProceedings of the National Academy of Sciences of the United States of America, 2008
- Recombinant Adeno-associated Virus Transduction and IntegrationMolecular Therapy, 2008
- Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower dosesProceedings of the National Academy of Sciences of the United States of America, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Novel AAV serotypes for improved ocular gene transferThe Journal of Gene Medicine, 2008
- Designer Gene Delivery Vectors: Molecular Engineering and Evolution of Adeno-Associated Viral Vectors for Enhanced Gene TransferPharmaceutical Research, 2007
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999